Drug Type Small molecule drug |
Synonyms Echitop S, 에치탑에스캡슐 |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists), adrenergic receptor agonists(Adrenergic receptors agonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (11 Nov 2024), |
Regulation- |
Molecular FormulaC11H17NO |
InChIKeyFMCGSUUBYTWNDP-ONGXEEELSA-N |
CAS Registry552-79-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cough | KR | 11 Nov 2024 |